NCT03859076 (MB-BP) is a NA clinical trial of MB-BP in Hypertension, sponsored by Brown University.

Who is sponsoring NCT03859076?

NCT03859076 is sponsored by Brown University.

What drugs are being tested in NCT03859076?

Interventions in NCT03859076: MB-BP, Enhanced Usual Care Control.

What condition does NCT03859076 study?

NCT03859076 studies Hypertension, Prehypertension.

Is NCT03859076 still recruiting?

NCT03859076 is currently completed. Last updated 13 January 2021.

Last reviewed 2021-01-13 · How we verify

NCT03859076: MB-BP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

UH3 Phase - Mindfulness-Based Blood Pressure Reduction (MB-BP) : Stage 2a RCT

Completed NA Last updated 13 January 2021

What this trial tests

NA trial testing MB-BP in Hypertension in 119 participants. Completed in 12 November 2020.

Timeline

13 December 2018

Primary endpoint
31 August 2020

12 November 2020

Quick facts

Lead sponsor	Brown University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	119
Start date	13 December 2018
Primary completion	31 August 2020
Estimated completion	12 November 2020
Sites	1 location across United States

Drugs / interventions tested

MB-BP
Enhanced Usual Care Control

Conditions studied

Hypertension — all drugs for Hypertension →
Prehypertension — all drugs for Prehypertension →

Sponsor

Brown University

Who can join

18 and older, any sex, with Hypertension or Prehypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary aim is to identify the impacts of a behavioral intervention called "Mindfulness-Based Blood Pressure Reduction" (MB-BP) vs. enhanced usual care on the primary self-regulation target, specifically an assay of self-related processes (Multidimensional Assessment of Interoceptive Awareness) (MAIA) at 6 months, via a randomized controlled trial.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Effect of Adapted Mindfulness Training in Participants With Elevated Office Blood Pressure: The MB-BP Study: A Randomized Clinical Trial.
Loucks EB, Schuman-Olivier Z, Saadeh FB, Scarpaci MM, et al · · 2023 · cited 17× · PMID 37218591 · DOI 10.1161/jaha.122.028712
Adapted Mindfulness Training for Interoception and Adherence to the DASH Diet: A Phase 2 Randomized Clinical Trial.
Loucks EB, Kronish IM, Saadeh FB, Scarpaci MM, et al · · 2023 · cited 16× · PMID 37917063 · DOI 10.1001/jamanetworkopen.2023.39243
Meditation for the primary and secondary prevention of cardiovascular disease.
Rees K, Takeda A, Court R, Kudrna L, et al · · 2024 · cited 5× · PMID 38358047 · DOI 10.1002/14651858.cd013358.pub2
Effects of Adapted Mindfulness Training on Interoception and Adherence to the Dietary Approaches to Stop Hypertension (DASH) Diet: The MB-BP Randomized Clinical Trial
Loucks EB, Kronish IM, Saadeh FB, Scarpaci MM, et al · · 2023 · DOI 10.1101/2023.05.10.23289818

Verify or expand the search:

Other recruiting trials for Hypertension

Currently open trials in the same condition.

NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting

Other Brown University trials

Trials by the same sponsor.

NCT07502872 — TPG: Tafasitamab, Polatuzumab Vedotin, and Glofitamab as First-line Therapy for Diffuse Large B-cell Lymphoma and High-g · Phase 2 · not yet recruiting
NCT07118618 — Probenecid Administration for Alcohol Craving and Consumption · Phase 2 · recruiting
NCT07398443 — Using Novel Behavioral Economic Measures to Characterize Dual Marijuana and Tobacco Use in Young Adults · NA · recruiting
NCT05901766 — Effect of Iodine-containing Multiple Micronutrient During Lactation on Infant Neurodevelopment · Phase 4 · not yet recruiting
NCT06974604 — Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03859076 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Brown University
Last refreshed: 13 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03859076.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing